抗球蟲藥物市場－全球產業規模、佔有率、趨勢、機會及預測（依藥物類別、藥物作用機制、動物類型、配銷通路、地區及競爭格局分類，2020-2030 年預測）

2024年全球抗球蟲藥市場規模為14.1億美元，預計2030年將以3.96%的複合年成長率成長至17.8億美元。抗球蟲藥是用於預防和治療球蟲病的藥物，球蟲病是一種主要影響牲畜（尤其是家禽）腸道的寄生蟲病，由艾美球蟲屬（Eimeria）原生動物引起。全球對動物性蛋白質的需求不斷成長，導致集約化養殖方式的普及，進而增加了球蟲病的發生率，這從根本上推動了該市場的成長。

主要市場促進因素

全球抗球蟲藥物市場正經歷顯著擴張，這主要受畜禽球蟲病流行率不斷攀升以及全球對動物性蛋白質需求日益成長的推動。由艾美球蟲引起的球蟲病傳播廣泛，因此，必須持續採取有效的藥物干預措施來維護動物的健康和生產力。

主要市場挑戰

抗藥性球蟲菌株的不斷出現嚴重阻礙了全球抗球蟲藥物市場的成長。這一普遍存在的問題直接削弱了現有藥物治療的療效，因此需要不斷創新，並加強研發投入，以開發新型化合物和治療策略。

主要市場趨勢

轉向天然益生菌和益生元等天然成分的球蟲病防治方法代表著一個重要的趨勢，其促進因素包括消費者對無殘留動物產品的需求不斷成長，以及行業應對抗藥性挑戰的迫切需求。生產者擴大在飼料中添加益生菌和益生元等添加劑，以促進腸道健康，增強動物的天然免疫力。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球抗球蟲藥物市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依藥物類別（離子載體、抗生素、磺胺類藥物、化學衍生物、其他藥物類別）
  • 依藥物作用機轉（抑球蟲藥、殺球蟲藥）
  • 依動物類型（生產動物、伴侶動物）
  • 按配銷通路（獸醫院、零售藥局、其他分銷管道）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美抗球蟲藥物市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲抗球蟲藥物市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區抗球蟲藥市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲抗球蟲藥物市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲抗球蟲藥物市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球抗球蟲藥物市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Vetoquinol SA
• Zoetis Philippines Inc.
• Phibro Animal Health Corporation
• Huvepharma, Inc.
• Elanco US Inc.
• Biochem Pharmaceutical Industries Ltd
• Ceva Sante Animale SA
• Impextraco NV
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Anticoccidial Drugs Market, valued at USD 1.41 Billion in 2024, is projected to experience a CAGR of 3.96% to reach USD 1.78 Billion by 2030. Anticoccidial drugs are pharmaceutical agents developed to prevent and treat coccidiosis, a parasitic disease primarily impacting the intestinal tracts of livestock, particularly poultry, caused by protozoa of the genus *Eimeria*. The market's growth is fundamentally supported by the escalating global demand for animal protein, leading to intensive farming practices that increase coccidiosis incidence.

Key Market Drivers

The global anticoccidial drugs market experiences significant expansion driven by the escalating prevalence of coccidiosis in livestock and poultry, coupled with a growing global demand for animal protein. The widespread nature of coccidiosis, caused by *Eimeria* protozoa, consistently necessitates effective pharmaceutical interventions to maintain animal health and productivity.

Key Market Challenges

The continuous development of drug-resistant coccidia strains presents a significant impediment to the growth of the Global Anticoccidial Drugs Market. This pervasive issue directly undermines the effectiveness of existing pharmaceutical treatments, necessitating constant innovation and substantial investment in research and development for novel compounds and treatment strategies. As existing drugs become less potent against evolved parasite strains, their market value and utility diminish, compelling manufacturers to shoulder considerable costs for developing new solutions. This prolonged and costly development cycle for effective new drugs, coupled with the shortened effective lifespan of current products due to resistance, directly stifles overall market expansion.

Key Market Trends

The shift towards natural and probiotic-based coccidiosis management represents a significant trend, driven by increasing consumer demand for residue-free animal products and the industry's need to address drug resistance challenges. Producers are increasingly incorporating feed additives, such as probiotics and prebiotics, to foster robust gut health and enhance the animals' natural immunity. This approach reduces reliance on conventional anticoccidial drugs.

Key Market Players

• Vetoquinol SA
• Zoetis Philippines Inc.
• Phibro Animal Health Corporation
• Huvepharma, Inc.
• Elanco US Inc.
• Biochem Pharmaceutical Industries Ltd
• Ceva Sante Animale SA
• Impextraco NV
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.

Report Scope:

In this report, the Global Anticoccidial Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anticoccidial Drugs Market, By Drug Class:

• Ionophore
• Antibiotic
• Sulphonamides
• Chemical Derivative
• Other Drug Classes

Anticoccidial Drugs Market, By Drug Action:

• Coccidiostatic
• Coccidiocidal

Anticoccidial Drugs Market, By Animal Type:

• Production Animals
• Companion Animals

Anticoccidial Drugs Market, By Distribution Channel:

• Veterinary Hospitals
• Retail Pharmacy
• Other Distribution Channels

Anticoccidial Drugs Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Anticoccidial Drugs Market.

Available Customizations:

Global Anticoccidial Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anticoccidial Drugs Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes)
  • 5.2.2. By Drug Action (Coccidiostatic, Coccidiocidal)
  • 5.2.3. By Animal Type (Production Animals, Companion Animals)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Anticoccidial Drugs Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Class
  • 6.2.2. By Drug Action
  • 6.2.3. By Animal Type
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anticoccidial Drugs Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Class
      • 6.3.1.2.2. By Drug Action
      • 6.3.1.2.3. By Animal Type
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Anticoccidial Drugs Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Class
      • 6.3.2.2.2. By Drug Action
      • 6.3.2.2.3. By Animal Type
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Anticoccidial Drugs Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Class
      • 6.3.3.2.2. By Drug Action
      • 6.3.3.2.3. By Animal Type
      • 6.3.3.2.4. By Distribution Channel

7. Europe Anticoccidial Drugs Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Class
  • 7.2.2. By Drug Action
  • 7.2.3. By Animal Type
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anticoccidial Drugs Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Class
      • 7.3.1.2.2. By Drug Action
      • 7.3.1.2.3. By Animal Type
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Anticoccidial Drugs Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Class
      • 7.3.2.2.2. By Drug Action
      • 7.3.2.2.3. By Animal Type
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Anticoccidial Drugs Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Class
      • 7.3.3.2.2. By Drug Action
      • 7.3.3.2.3. By Animal Type
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Anticoccidial Drugs Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Class
      • 7.3.4.2.2. By Drug Action
      • 7.3.4.2.3. By Animal Type
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Anticoccidial Drugs Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Class
      • 7.3.5.2.2. By Drug Action
      • 7.3.5.2.3. By Animal Type
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Anticoccidial Drugs Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Class
  • 8.2.2. By Drug Action
  • 8.2.3. By Animal Type
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Anticoccidial Drugs Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Class
      • 8.3.1.2.2. By Drug Action
      • 8.3.1.2.3. By Animal Type
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Anticoccidial Drugs Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Class
      • 8.3.2.2.2. By Drug Action
      • 8.3.2.2.3. By Animal Type
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Anticoccidial Drugs Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Class
      • 8.3.3.2.2. By Drug Action
      • 8.3.3.2.3. By Animal Type
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Anticoccidial Drugs Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Class
      • 8.3.4.2.2. By Drug Action
      • 8.3.4.2.3. By Animal Type
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Anticoccidial Drugs Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Class
      • 8.3.5.2.2. By Drug Action
      • 8.3.5.2.3. By Animal Type
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Anticoccidial Drugs Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Class
  • 9.2.2. By Drug Action
  • 9.2.3. By Animal Type
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Anticoccidial Drugs Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Class
      • 9.3.1.2.2. By Drug Action
      • 9.3.1.2.3. By Animal Type
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Anticoccidial Drugs Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Class
      • 9.3.2.2.2. By Drug Action
      • 9.3.2.2.3. By Animal Type
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Anticoccidial Drugs Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Class
      • 9.3.3.2.2. By Drug Action
      • 9.3.3.2.3. By Animal Type
      • 9.3.3.2.4. By Distribution Channel

10. South America Anticoccidial Drugs Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Class
  • 10.2.2. By Drug Action
  • 10.2.3. By Animal Type
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Anticoccidial Drugs Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Class
      • 10.3.1.2.2. By Drug Action
      • 10.3.1.2.3. By Animal Type
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Anticoccidial Drugs Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Class
      • 10.3.2.2.2. By Drug Action
      • 10.3.2.2.3. By Animal Type
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Anticoccidial Drugs Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Class
      • 10.3.3.2.2. By Drug Action
      • 10.3.3.2.3. By Animal Type
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Anticoccidial Drugs Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Vetoquinol SA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Zoetis Philippines Inc.
• 15.3. Phibro Animal Health Corporation
• 15.4. Huvepharma, Inc.
• 15.5. Elanco US Inc.
• 15.6. Biochem Pharmaceutical Industries Ltd
• 15.7. Ceva Sante Animale SA
• 15.8. Impextraco NV
• 15.9. Boehringer Ingelheim International GmbH
• 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer